TITLE

New Advances and Novel Treatments in Heart Failure

AUTHOR(S)
Smith, Andrew Lee; Brown, Carolyn S.
PUB. DATE
February 2003
SOURCE
Critical Care Nurse;Feb2003 Supplement, Vol. 23, p11
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Provides information on medical advances and novel treatments in heart failure. Epidemiology and cost of heart failure; Pathophysiology of heart failure; Effects of nesiritide on hemodynamic and neurohormonal parameters in acute heart failure.
ACCESSION #
9134587

 

Related Articles

  • Heart rate alternans. Binkley, Philip E.; Eaton, Gregory M. // Annals of Internal Medicine;1/15/95, Vol. 122 Issue 2, p115 

    Presents a case study of beat-to-beat variation in heart rate or `heart rate alternans' in a patient with congestive heart failure. Heart rate alternans as a manifestation of pulsus alternans; Hemodynamic evaluation of the patient; Electrocardiography; High-frequency heart rate oscillation.

  • Systolic Strain Abnormalities to Predict Hospital Readmission in Patients With Heart Failure and Normal Ejection Fraction. Borer, Steven M.; Kokkirala, Aravind; O'Sullivan, David M.; Silverman, David I. // Cardiology Research;2011, Vol. 2 Issue 6, p274 

    Background: Despite intensive investigation, the pathogenesis of heart failure with normal ejection fraction (HFNEF) remains unclear. We hypothesized that subtle abnormalities of systolic function might play a role, and that abnormal systolic strain and strain rate would provide a marker for...

  • Pulmonary Hypertension: A Review for Nurses. Yates, Gillian; Saunders, Kelly // Canadian Journal of Cardiovascular Nursing;2008, Vol. 18 Issue 1, p7 

    Pulmonary hypertension (PH) is a progressive disease resulting from increased pulmonary vasoconstriction, vascular remodelling and thrombosis, leading to right heart failure. Symptoms at clinical presentation are often vague and difficult to differentiate from other diseases. A good history and...

  • Heart failure, renal function, and angiotensin converting enzyme inhibitors. Cleland, John G. F.; Dargie, Henry J. // Kidney International Supplement;May1987, Issue 20, p220 

    Focuses on the effects of angiotensin converting enzyme (ACE) inhibitors on renal function in heart failure secondary to left ventricular dysfunction in man. Pathophysiologic considerations; Renal hemodynamics in heart failure; Renal sodium excretion in heart failure; Acute studies; Medium-term...

  • The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment. Volpe, Massimo; Carnovali, Marino; Mastromarino, Vittoria // Clinical Science;1/15/2016, Vol. 130 Issue 2, p57 

    After its discovery in the early 1980s, the natriuretic peptide (NP) system has been extensively characterized and its potential influence in the development and progression of heart failure (HF) has been investigated. HF is a syndrome characterized by the activation of different neurohormonal...

  • Sildenafil and Exercise Capacity in Heart Failure. Guazzi, Marco; Bandera, Francesco; Forfia, Paul; Redfield, Margaret M.; Borlaug, Barry A. // JAMA: Journal of the American Medical Association;7/24/2013, Vol. 310 Issue 4, p432 

    A letter to the editor and a response from the author of the article "Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment" that was published in the earlier edition of the journal is presented.

  • Atrial natriuretic peptides in heart failure: pathophysiological significance, diagnostic and prognostic value. Ghosh, Nina; Haddad, Haissam // Canadian Journal of Physiology & Pharmacology;Aug2011, Vol. 89 Issue 8, p587 

    Neurohormonal activation in patients with heart failure is dominated by the deleterious long-term effects of activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system. The natriuretic peptides, including brain natriuretic peptide (BNP) and atrial natriuretic...

  • Systolic and diastolic heart failure: Different phenotypes of the same disease? De Keulenaer, Gilles W.; Brutsaert, Dirk L. // European Journal of Heart Failure;Feb2007, Vol. 9 Issue 2, p136 

    Abstract: Traditional pathophysiological concepts of chronic heart failure have largely focused on the haemodynamic consequences of ventricular systolic dysfunction. How these concepts relate to the pathophysiology of diastolic heart failure, i.e., heart failure with a preserved ejection...

  • Safety and Effectiveness of Levosimendan in Patients with Predominant Right Heart Failure. Ralph Zwick; Willhelm Grander; Bernhard Metzler; Patrycja Jonetzko; Mathias Frick; Hanno Ulmer; Otmar Pachinger; Franz Roithinger // Herz;Jul2008, Vol. 33 Issue 5, p368 

    Abstract Background and Purpose:   Levosimendan is a new calcium sensitizer that enhances the contractile force of the myocardium and exhibits additional vasodilating properties. The present study describes the hemodynamic effects of levosimendan in patients with acute predominant right...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics